Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by excessive insulin production, leading to low blood sugar levels, which can cause severe complications if not properly managed. The Northern Congenital Hyperinsulinism (NORCHI) service, based in Manchester, is a leading center dedicated to providing expert care and support for individuals affected by CHI. With cutting-edge diagnostics, personalized treatment plans, and a team of specialized professionals, NORCHI plays a crucial role in managing this condition. For more comprehensive information and resources, please visit the NORCHI website.
